Sight Sciences, Inc.
SGHT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $180,180 | $214,024 | $123,098 | $184,901 |
| - Cash | $92,373 | $101,500 | $108,768 | $120,357 |
| + Debt | $0 | $40,570 | $40,463 | $40,362 |
| Enterprise Value | $87,807 | $153,094 | $54,793 | $104,906 |
| Revenue | $19,906 | $19,564 | $17,508 | $19,074 |
| % Growth | 1.7% | 11.7% | -8.2% | – |
| Gross Profit | $17,197 | $16,587 | $15,094 | $16,561 |
| % Margin | 86.4% | 84.8% | 86.2% | 86.8% |
| EBITDA | -$6,837 | -$10,492 | -$12,701 | -$10,471 |
| % Margin | -34.3% | -53.6% | -72.5% | -54.9% |
| Net Income | -$8,169 | -$11,941 | -$14,154 | -$11,846 |
| % Margin | -41% | -61% | -80.8% | -62.1% |
| EPS Diluted | -0.16 | -0.23 | -0.28 | -0.23 |
| % Growth | 30.4% | 17.9% | -21.7% | – |
| Operating Cash Flow | -$8,719 | -$7,543 | -$11,605 | -$3,459 |
| Capital Expenditures | -$170 | -$210 | $0 | -$137 |
| Free Cash Flow | -$8,889 | -$7,753 | -$11,605 | -$3,596 |